Sphaeranthus indicus Linn ameliorates streptozotocin-induced experimental diabetic neuropathy by targeting oxidative stress-mediated alterations

[1] Wild S(2004)Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047-1053

[2] Roglic G(2017)Diabetic neuropathy: current status and future prospects J Diabetes Res 2017 555-29

[3] Green A(2006)An update on the etiology and epidemiology of diabetes mellitus Ann N Y Acad Sci 1084 1-119

[4] Sicree R(2018)A deep insight on diabetic neuropathy: the silent complication of diabetes, with inputs on its causes, diagnosis, pathways, and treatments Asian J Pharmaceut Clin Res 11 112-156

[5] King H(2015)From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy J Diabetes Complicat 29 146-61

[6] Tavakoli M(2014)Painful diabetic neuropathy: clinical aspects Handb Clin Neurol 126 53-628

[7] Yavuz DG(2004)Oxidative stress in the pathogenesis of diabetic neuropathy Endocr Rev 25 612-275

[8] Tahrani AA(2005)Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies Curr Med Chem 12 267-35

[9] Selvarajah D(2014)Diabetic peripheral neuropathy: current perspective and future directions Pharmacol Res 80 21-47

[10] Bowling FL(2015)Streptozotocin-induced diabetic models in mice and rats Curr Protoc Pharmacol 70 5-18

[1] Wild S(2004)Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047-1053

[2] Roglic G(2017)Diabetic neuropathy: current status and future prospects J Diabetes Res 2017 555-29

[3] Green A(2006)An update on the etiology and epidemiology of diabetes mellitus Ann N Y Acad Sci 1084 1-119

[4] Sicree R(2018)A deep insight on diabetic neuropathy: the silent complication of diabetes, with inputs on its causes, diagnosis, pathways, and treatments Asian J Pharmaceut Clin Res 11 112-156

[5] King H(2015)From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy J Diabetes Complicat 29 146-61

[6] Tavakoli M(2014)Painful diabetic neuropathy: clinical aspects Handb Clin Neurol 126 53-628

[7] Yavuz DG(2004)Oxidative stress in the pathogenesis of diabetic neuropathy Endocr Rev 25 612-275

[8] Tahrani AA(2005)Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies Curr Med Chem 12 267-35

[9] Selvarajah D(2014)Diabetic peripheral neuropathy: current perspective and future directions Pharmacol Res 80 21-47

[10] Bowling FL(2015)Streptozotocin-induced diabetic models in mice and rats Curr Protoc Pharmacol 70 5-18